Effectiveness Of The Fibulock Intramedullary Nail

Completed

Conditions studied: Fibula Fracture

In brief

The objective of this post-market clinical study is to evaluate efficacy outcomes and complication rates in patients who have received the Fibulock™ Intramedullary Nail.

Key facts

Study ID

NCT02688296

Run by

Arthrex, Inc.

People needed

34

Starts

2016-05-24

Expected to finish

2020-07-09

Last updated by the study team

2021-01-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• An unstable fibula fracture.
• Must be less than 31 weeks post-implantation
• Must have received surgical treatment with the Fibulock Intramedullary Nail for their unstable fibula - fracture
• Male or female greater than or equal to 18 years of age and skeletally mature.
• Able to understand the requirements of the study, provide a written informed consent and comply with the study protocol
• Ability to understand and provide written authorization for use and disclosure of personal health information.

You may not qualify if…

• Patients who are not implanted with a Sonoma Fibulock IM Nail

Where it is running

• Baptist Health South Florida — Miami, Florida, United States
• NCOC — Durham, North Carolina, United States
• Orthopedic Foot & Ankle Center — Westerville, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.